SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin
- PMID: 33662449
- PMCID: PMC7919585
- DOI: 10.1016/j.pharmthera.2021.107825
SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin
Abstract
Coronaviruses (CoVs) are a group of single stranded RNA viruses, of which some of them such as SARS-CoV, MERS-CoV, and SARS-CoV-2 are associated with deadly worldwide human diseases. Coronavirus disease-2019 (COVID-19), a condition caused by SARS-CoV-2, results in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with high mortality in the elderly and in people with underlying comorbidities. Results from several studies suggest that CoVs localize in mitochondria and interact with mitochondrial protein translocation machinery to target their encoded products to mitochondria. Coronaviruses encode a number of proteins; this process is essential for viral replication through inhibiting degradation of viral proteins and host misfolded proteins including those in mitochondria. These viruses seem to maintain their replication by altering mitochondrial dynamics and targeting mitochondrial-associated antiviral signaling (MAVS), allowing them to evade host innate immunity. Coronaviruses infections such as COVID-19 are more severe in aging patients. Since endogenous melatonin levels are often dramatically reduced in the aged and because it is a potent anti-inflammatory agent, melatonin has been proposed to be useful in CoVs infections by altering proteasomal and mitochondrial activities. Melatonin inhibits mitochondrial fission due to its antioxidant and inhibitory effects on cytosolic calcium overload. The collective data suggests that melatonin may mediate mitochondrial adaptations through regulating both mitochondrial dynamics and biogenesis. We propose that melatonin may inhibit SARS-CoV-2-induced cell damage by regulating mitochondrial physiology.
Keywords: Apoptosis; Autophagy; COVID-19; Chaperone proteins; Coronaviruses; Fission; Fusion; Melatonin; Mitochondrial dynamics.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement The authors declare that there are no conflicts of interest.
Figures


Similar articles
-
SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.J Immunol. 2014 Sep 15;193(6):3080-9. doi: 10.4049/jimmunol.1303196. Epub 2014 Aug 18. J Immunol. 2014. PMID: 25135833 Free PMC article.
-
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2. Virol J. 2020. PMID: 32907596 Free PMC article.
-
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.Int J Biol Sci. 2020 Mar 15;16(10):1724-1731. doi: 10.7150/ijbs.45498. eCollection 2020. Int J Biol Sci. 2020. PMID: 32226290 Free PMC article. Review.
-
Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C258-C267. doi: 10.1152/ajpcell.00224.2020. Epub 2020 Jun 8. Am J Physiol Cell Physiol. 2020. PMID: 32510973 Free PMC article.
-
Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.Mitochondrion. 2023 Mar;69:43-56. doi: 10.1016/j.mito.2023.01.005. Epub 2023 Jan 20. Mitochondrion. 2023. PMID: 36690315 Free PMC article. Review.
Cited by
-
Melatonin and neuroblastoma: a novel therapeutic approach.Mol Biol Rep. 2021 May;48(5):4659-4665. doi: 10.1007/s11033-021-06439-1. Epub 2021 Jun 1. Mol Biol Rep. 2021. PMID: 34061325 Review.
-
Mitochondria in COVID-19: from cellular and molecular perspective.Front Physiol. 2024 Jun 21;15:1406635. doi: 10.3389/fphys.2024.1406635. eCollection 2024. Front Physiol. 2024. PMID: 38974521 Free PMC article. Review.
-
Melatonin and oral diseases: possible therapeutic roles based on cellular mechanisms.Pharmacol Rep. 2024 Jun;76(3):487-503. doi: 10.1007/s43440-024-00593-6. Epub 2024 Apr 12. Pharmacol Rep. 2024. PMID: 38607587 Review.
-
Targeting mitochondrial quality control: new therapeutic strategies for major diseases.Mil Med Res. 2024 Aug 21;11(1):59. doi: 10.1186/s40779-024-00556-1. Mil Med Res. 2024. PMID: 39164792 Free PMC article. Review.
-
Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications.J Clin Med. 2023 Jun 25;12(13):4253. doi: 10.3390/jcm12134253. J Clin Med. 2023. PMID: 37445288 Free PMC article.
References
-
- Acuna-Castroviejo D., Escames G., Rodriguez M.I., Lopez L.C. Melatonin role in the mitochondrial function. Frontiers in Bioscience. 2007;12:947–963. - PubMed
-
- Ahluwalia A., Brzozowska I.M., Hoa N., Jones M.K., Tarnawski A.S. Melatonin signaling in mitochondria extends beyond neurons and neuroprotection: Implications for angiogenesis and cardio/gastroprotection. Proceedings of the National Academy of Sciences of the United States of America. 2018;115:E1942–E1943. - PMC - PubMed
-
- Ahmed E.A. Recommendations for oncological surgical practice in COVID-19 pandemics: A review of literature. Sohag Medical Journal. 2020;24:63–68.
-
- Andersen L.P.H., Gögenur I., Rosenberg J., Reiter R.J. Pharmacokinetics of melatonin: The missing link in clinical efficacy? Clinical Pharmacokinetics. 2016;55:1027–1030. - PubMed
-
- Andersen L.P.H., Gögenur I., Rosenberg J., Reiter R.J. The safety of melatonin in humans. Clinical Drug Investigation. 2016;36:169–175. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous